Merz Aesthetics, a global leader in medical aesthetics, is celebrating 15 years of XEOMIN® (incobotulinumtoxinA), its flagship neurotoxin brand, being FDA-approved for aesthetic use in the United States. To commemorate this milestone, the company is offering 15 individuals the chance to win a year of free XEOMIN® treatments as part of a celebratory sweepstakes.

A Milestone in Aesthetic Innovation

Since its FDA approval for cosmetic applications, XEOMIN® has become a trusted name in the treatment of upper facial lines, including forehead lines, frown lines, and crow’s feet. The product is distinguished by its unique double-purified formulation, achieved through Merz Aesthetics’ XTRACT Technology®, which removes unnecessary proteins that could potentially result in treatment resistance. With over 43 million vials shipped globally, the product has solidified its position as a leader in the neurotoxin market.

Patrick Urban, President of Merz Aesthetics North America, emphasized the significance of the anniversary, stating, "Since its debut, XEOMIN® has been a trusted choice for patients and providers seeking effective, natural-looking results. Celebrating 15 years is more than a milestone - it’s a testament to our unwavering commitment to proven performance and advancing aesthetic care."

A New Campaign to Empower Patients

In addition to the sweepstakes, Merz Aesthetics is unveiling a refreshed marketing campaign designed to highlight XEOMIN®’s ability to deliver natural-looking results. The new initiative spans digital platforms and in-office touchpoints, encouraging patients to request XEOMIN® by name and explore its benefits.

"Leveraging our proprietary XTRACT Technology® manufacturing process, we have established ourselves as a pioneer in neurotoxins, delivering outcomes and efficacy that both patients and providers expect", explained Dr. Samantha Kerr, Chief Scientific Officer at Merz Aesthetics. "We’re committed to driving continued innovation for years to come."

The campaign underscores XEOMIN®’s clinical effectiveness, as evidenced by a 96% patient satisfaction rate and its consistent performance in smoothing upper facial lines. Clinical trials have shown no development of treatment resistance due to neutralizing antibodies, a benefit attributed to its purified formulation.

Sweepstakes Details

The celebratory sweepstakes gives participants the chance to win free XEOMIN® treatments for an entire year. From February 11 to March 11, 2026, eligible U.S. patients can enter the contest through Merz Aesthetics’ Xperience+ loyalty program. Fifteen winners will be selected to experience XEOMIN® treatments from participating providers.

This milestone shines a spotlight on both the innovation behind XEOMIN® and the company’s dedication to empowering consumers to look and feel their best. As Merz Aesthetics continues to celebrate its success, the company remains committed to advancing aesthetic care for patients and providers alike.

For further information on XEOMIN®, its uses, or safety information, patients are encouraged to consult their healthcare provider.

Quotes from the Source

  • "Since its debut, XEOMIN® has been a trusted choice for patients and providers seeking effective, natural-looking results", said Patrick Urban, President, North America, Merz Aesthetics.
  • "Celebrating 15 years is more than a milestone - it’s a testament to our unwavering commitment to proven performance and advancing aesthetic care."
  • "Leveraging our proprietary XTRACT Technology® manufacturing process, we have established ourselves as a pioneer in neurotoxins, delivering outcomes and efficacy that both patients and providers expect", said Dr. Samantha Kerr, Chief Scientific Officer, Merz Aesthetics.

Read the source